Classification by Mechanism of Action
The pharmacological response of helminths to therapy depends on the drug's site of action. There are two main groups:
- Microtubule synthesis inhibitors (e.g., mebendazole). These drugs disrupt tubulin polymerization, thereby blocking nutrient transport directly within the helminth's cells.
- Neuromuscular blocking agents (e.g., pyrantel). These substances induce spastic paralysis in nematodes, facilitating their easy elimination from the intestinal lumen.
Spectrum of Activity and Pathogen Localization
Drug selection is directly related to the exact habitat of the parasite and its class:
- Intestinal helminthiases: For infections localized to the gastrointestinal lumen, pyrantel, mebendazole, and niclosamide are used.
- Extraintestinal helminthiases: Tissue invasions require agents with good bioavailability and tissue distribution, such as diethylcarbamazine and hexachloroparaxylene (chloxyl).
- Mebendazole is highly effective against nematodiases, including enterobiasis and ascariasis.
- Diethylcarbamazine serves as the drug of choice for extraintestinal filariases.
Classification by Parasite Type (Cestodes, Nematodes, Trematodes)
For precise therapeutic selection, it is important to consider the helminth class:
- Tapeworms (Cestodes): Niclosamide is a narrow-spectrum anticestodal agent for intestinal forms (beef tapeworm, fish tapeworm). Praziquantel has a broader spectrum—it is active against cestodes and trematodes and is also used for extraintestinal infections.
- Roundworms (Nematodes): Pyrantel is a specific antinematodal agent. Mebendazole has a broad spectrum but is clinically used primarily for nematodiases (ascariasis, enterobiasis, trichuriasis) and mixed infections.
- Flukes (Trematodes): Hexachloroparaxylene (chloxyl) is classified as an antitrematodal drug and is used mainly for extraintestinal forms such as opisthorchiasis.